Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1999894 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Thioredoxin Reductase 1 (TXNRD1) (AA 161-647) antibody
- Antibody type
- Polyclonal
- Antigen
- Other
- Description
- Affinity Purified
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 161-647
- Isotype
- IgG
- Vial size
- 50 μg
- Storage
- This antibody can be stored at 2°C-8°C for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20°C to -70°C.
- Handling
- Preservative-Free. Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
Submitted references Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study.
The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis.
Evidence for intriguingly complex transcription of human thioredoxin reductase 1.
Sobieszczyk ME, Hoover DR, Anastos K, Mulligan K, Tan T, Shi Q, Gao W, Hyman C, Cohen MH, Cole SR, Plankey MW, Levine AM, Justman J, Women's Interagency HIV Study
Journal of acquired immune deficiency syndromes (1999) 2008 Jul 1;48(3):272-80
Journal of acquired immune deficiency syndromes (1999) 2008 Jul 1;48(3):272-80
The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis.
Fritz-Wolf K, Urig S, Becker K
Journal of molecular biology 2007 Jun 29;370(1):116-27
Journal of molecular biology 2007 Jun 29;370(1):116-27
Evidence for intriguingly complex transcription of human thioredoxin reductase 1.
Rundlöf AK, Janard M, Miranda-Vizuete A, Arnér ES
Free radical biology & medicine 2004 Mar 1;36(5):641-56
Free radical biology & medicine 2004 Mar 1;36(5):641-56
No comments: Submit comment
No validations: Submit validation data